Skip to content

Discontinued — last reported Q1 '26

EBIT at other companies

Balchem logo
BalchemBCPC
$55.63M+9.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
STERIS logo
STERISSTE
Fortive logo
FortiveFTV
Natera, Inc. logo
Natera, Inc.NTRA
Oklo logo
OkloOKLO

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Calculated from Sotera Health’s reported figures.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's EBIT?
Sotera Health (SHC) reported EBIT of $7.87M in Q1 2026.
How has Sotera Health's EBIT changed year-over-year?
Sotera Health's EBIT increased by 114.1% year-over-year, from -$55.7M to $7.87M.
What is the long-term trend for Sotera Health's EBIT?
Over 4 years (2021 to 2025), Sotera Health's EBIT has grown at a -57.7% compound annual growth rate (CAGR), from $256.73M to -$8.22M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.